XEROX HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Total Revenues	$ 1,578	$ 1,754	$ 3,080	$ 3,469
Costs and Expenses
Cost of financing	29	34	56	70
Research, development and engineering expenses	50	57	99	121
Selling, administrative and general expenses	393	433	790	840
Restructuring and related costs, net	12	23	51	25
Amortization of intangible assets	10	10	20	21
Divestitures	(3)	0	51	0
PARC Donation	0	132	0	132
Other expenses, net	33	31	77	51
Total Costs and Expenses	1,553	1,843	3,205	3,473
Income (Loss) before Income Taxes	25	(89)	(125)	(4)
Income tax expense (benefit)	7	(28)	(30)	(14)
Net Income (Loss)	18	(61)	(95)	10
Less: Preferred stock dividends, net	(3)	(3)	(7)	(7)
Net Income (Loss) Attributable to Common Shareholders	$ 15	$ (64)	$ (102)	$ 3
Basic Earnings (Loss) per Share (in dollars per share)	$ 0.12	$ (0.41)	$ (0.83)	$ 0.02
Diluted Earnings (Loss) per Share (in dollars per share)	$ 0.11	$ (0.41)	$ (0.83)	$ 0.02
Sales
Revenues
Total Revenues	$ 611	$ 696	$ 1,134	$ 1,355
Costs and Expenses
Cost of sales/services, maintenance and rentals	387	452	727	877
Services, maintenance and rentals
Revenues
Total Revenues	929	1,009	1,866	2,013
Costs and Expenses
Cost of sales/services, maintenance and rentals	642	671	1,334	1,336
Financing
Revenues
Total Revenues	$ 38	$ 49	$ 80	$ 101